Acumen Pharmaceuticals, Inc. (ABOS) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -105.04M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-105.04M | (m) |
| 2026-03-31 | (m) | $-113.28M | (m) |
| 2025-12-31 | (m) | $-121.33M | (m) |
| 2025-09-30 | (m) | $-133.35M | (m) |
| 2025-06-30 | (m) | $-136.66M | (m) |
| 2025-03-31 | (m) | $-116.25M | (m) |
| 2024-12-31 | (m) | $-102.33M | (m) |
| 2024-09-30 | (m) | $-81.67M | (m) |
| 2024-06-30 | (m) | $-64.86M | (m) |
| 2024-03-31 | (m) | $-55.94M | (m) |
| 2023-12-31 | (m) | $-52.37M | (m) |
| 2023-09-30 | (m) | $-48.74M | (m) |
| 2023-06-30 | (m) | $-46.49M | (m) |
| 2023-03-31 | (m) | $-45.03M | (m) |
| 2022-12-31 | (m) | $-42.86M | (m) |
| 2022-09-30 | (m) | $-38.34M | (m) |
| 2022-06-30 | (m) | $-31.53M | (m) |
| 2022-03-31 | (m) | $-82.74M | (m) |
| 2021-12-31 | (m) | $-100.61M | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) |
| 2020-12-31 | (m) | $-7.33M | (m) |
| 2020-09-30 | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |